Case number 1:23-cv-00578
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 2, 2023 | N/A | Case associated with lead case: Create association to 1:22-cv-00336-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-cv-00336-CFC ONLY. (nmf) (Entered: 10/02/2023) (0) |
| Oct 2, 2023 | 30 | SO ORDERED, re (28 in 1:23-cv-00578-CFC, 119 in 1:22-cv-00336-CFC) STIPULATION and Order Regarding Case Consolidation. 1. Pursuant to Federal Rule of Civil Procedure 42(a), the -336 Action, the -924 Action, and the -578 Action are consolidated for all purposes. 2. The -336 Action shall be the lead case, and all future filings shall be made only in the -336 Action. Signed by Judge Colm F. Connolly on 10/2/2023. Associated Cases: 1:22-cv-00336-CFC, 1:23-cv-00578-CFC(nmf) (Entered: 10/02/2023) (5) |
| Sep 29, 2023 | 29 | Letter to The Honorable Colm F. Connolly from Ethan H. Townsend, Esq. regarding Proposed Scheduling Order. (Attachments: # 1 Text of Proposed Order Proposed Scheduling Order for Patent Cases in Which Infringement is Alleged)(Townsend, Ethan) (Entered: 09/29/2023) (0) |
| Sep 29, 2023 | 28 | STIPULATION and Proposed Order Regarding Case Consolidation by Alnylam Pharmaceuticals, Inc.. (Townsend, Ethan) (Entered: 09/29/2023) (5) |
| Sep 15, 2023 | 27 | NOTICE OF SERVICE of Disclosure of Asserted Claims and Infringement Contentions filed by Alnylam Pharmaceuticals, Inc..(Townsend, Ethan) (Entered: 09/15/2023) (2) |
| Sep 6, 2023 | 26 | NOTICE OF SERVICE of Initial Disclosures Pursuant to District of Delaware Default Standard for Discovery 3; and Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Alnylam Pharmaceuticals, Inc..(Townsend, Ethan) (Entered: 09/06/2023) (2) |
| Sep 1, 2023 | 25 | Letter to The Honorable Colm F. Connolly from Ethan H. Townsend, Esq. regarding Scheduling Order and Request for Scheduling Conference on behalf of the parties. (Attachments: # 1 Exhibit A)(Townsend, Ethan) (Entered: 09/01/2023) (0) |
| Sep 1, 2023 | 24 | NOTICE OF SERVICE of (1) Defendants BioNTech SE and BioNTech Manufacturing GmbH's Initial Disclosures Pursuant to Rule 26(a)(1) and (2) BioNTech's Paragraph 3 Initial Disclosures filed by BioNTech Manufacturing GmbH, BioNTech SE.(Tigan, Jeremy) (Entered: 09/01/2023) (6) |
| Sep 1, 2023 | 23 | NOTICE OF SERVICE of Pfizer Inc. and Pharmacia Upjohn Co. LLC's (1) Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information (ESI) and (2) Rule 26(a)(1) Initial Disclosures filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC.(Silverstein, Alan) (Entered: 09/01/2023) (3) |
| Aug 18, 2023 | N/A | SO ORDERED, re 21 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire Fundakowski, Jovial Wong, Katherine L. Kyman, Brian L. O'Gara and Ashley Graham of WINSTON & STRAWN LLP, filed by BioNTech Manufacturing GmbH, BioNTech SE. Ordered by Judge Colm F. Connolly on 8/18/2023. (kmd) (Entered: 08/18/2023) (0) |
| Aug 18, 2023 | N/A | Pro Hac Vice Attorney Dan Constantinescu,Michael W. Johnson, and Sara T. Horton for Pfizer Inc. and Pharmacia & Upjohn Co. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 08/18/2023) (0) |
| Aug 18, 2023 | 22 | ANSWER to 15 Answer to Counterclaim, by BioNTech Manufacturing GmbH, BioNTech SE.(Tigan, Jeremy) (Entered: 08/18/2023) (16) |
| Aug 18, 2023 | 21 | MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire Fundakowski, Jovial Wong, Katherine L. Kyman, Brian L. O'Gara and Ashley Graham of WINSTON & STRAWN LLP - filed by BioNTech Manufacturing GmbH, BioNTech SE. (Tigan, Jeremy) (Entered: 08/18/2023) (10) |
| Aug 18, 2023 | 20 | SO ORDERED, re 18 Joint STIPULATION TO EXTEND TIME to respond to Court's Order (D.I. 14) regarding coordination of related case to September 1, 2023, filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. Reset Deadlines: Notice of Compliance deadline set for 9/1/2023. Signed by Judge Colm F. Connolly on 8/18/2023. (kmd) (Entered: 08/18/2023) (3) |
| Aug 18, 2023 | N/A | SO ORDERED, re 19 MOTION for Pro Hac Vice Appearance of Attorney Sara Tonnies Horton, Michael W. Johnson, and Dan Constantinescu, filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. Ordered by Judge Colm F. Connolly on 8/18/2023. (kmd) (Entered: 08/18/2023) (0) |
| Aug 18, 2023 | 19 | MOTION for Pro Hac Vice Appearance of Attorney Sara Tonnies Horton, Michael W. Johnson, and Dan Constantinescu - filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. (Silverstein, Alan) (Entered: 08/18/2023) (5) |
| Aug 17, 2023 | 18 | Joint STIPULATION TO EXTEND TIME to respond to Court's Order (D.I. 14) regarding coordination of related case to September 1, 2023 - filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. (Silverstein, Alan) (Entered: 08/17/2023) (3) |
| Aug 17, 2023 | N/A | Pro Hac Vice Attorney Mandy H. Kim for Alnylam Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00580-CFC, 1:22-cv-00336-CFC, 1:23-cv-00578-CFC(mpb) (Entered: 08/17/2023) (0) |
| Aug 17, 2023 | N/A | SO ORDERED, re (17 in 1:23-cv-00578-CFC, 19 in 1:23-cv-00580-CFC) MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim, filed by Alnylam Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 8/17/2023. Associated Cases: 1:23-cv-00578-CFC, 1:23-cv-00580-CFC (kmd) (Entered: 08/17/2023) (0) |
| Aug 17, 2023 | 17 | MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim - filed by Alnylam Pharmaceuticals, Inc.. (Townsend, Ethan) (Entered: 08/17/2023) (3) |
| Aug 2, 2023 | 16 | Letter to The Honorable Colm F. Connolly from Ethan H. Townsend, Esq. regarding Coordination of Actions - re 14 Order,,, Set Deadlines,,. (Townsend, Ethan) (Entered: 08/02/2023) (2) |
| Jul 28, 2023 | 15 | ANSWER to 11 Answer to Complaint, Counterclaim , COUNTERCLAIM against BioNTech Manufacturing GmbH, BioNTech SE by Alnylam Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 44)(Townsend, Ethan) (Entered: 07/28/2023) (0) |
| Jul 19, 2023 | 14 | ORDER, having been assigned these cases which are listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before August 21, 2023, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 8/21/2023.) Signed by Judge Colm F. Connolly on 7/19/2023. Associated Cases: 1:23-cv-00578-CFC, 1:23-cv-00580-CFC(nmf) (Entered: 07/19/2023) (2) |
| Jul 17, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent BioNTech SE for BioNTech Manufacturing GmbH filed by BioNTech SE, BioNTech Manufacturing GmbH. (Tigan, Jeremy) (Entered: 07/17/2023) (4) |
| Jul 17, 2023 | 12 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. (Connolly, Arthur) (Entered: 07/17/2023) (2) |
| Jul 17, 2023 | 11 | ANSWER to 1 Complaint, , COUNTERCLAIM against Alnylam Pharmaceuticals, Inc. by Pharmacia & Upjohn Co. LLC, Pfizer Inc..(Connolly, Arthur) (Entered: 07/17/2023) (30) |
| Jun 13, 2023 | N/A | SO ORDERED, re 10 STIPULATION TO EXTEND TIME to Respond to the Complaint to July 17, 2023 filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. Reset Answer Deadlines: Pfizer Inc. answer due 7/17/2023; Pharmacia & Upjohn Co. LLC answer due 7/17/2023. Ordered by Judge Colm F. Connolly on 6/13/2023. (kmd) (Entered: 06/13/2023) (0) |
| Jun 13, 2023 | 10 | STIPULATION TO EXTEND TIME to Respond to the Complaint to July 17, 2023 - filed by Pfizer Inc., Pharmacia & Upjohn Co. LLC. (Silverstein, Alan) (Entered: 06/13/2023) (2) |
| Jun 13, 2023 | N/A | Pro Hac Vice Attorney William G. Gaede, III, Timothy M. Dunker, Anisa Noorassa, Sarah J. Fischer, Bhanu K. Sadasivan, Ian B. Brooks, and Sarah Chapin Columbia for Alnylam Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/13/2023) (0) |
| Jun 7, 2023 | N/A | CORRECTING ENTRY: D.I. 1 Exhibit's replaced due to corruption issue per counsel's request. (vfm) (Entered: 06/07/2023) (0) |
| Jun 2, 2023 | N/A | SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney William G. Gaede, III, Sarah Chapin Columbia, Ian B. Brooks, Sarah J. Fischer, Bhanu K. Sadasivan, Timothy M. Dunker, Anisa Noorassa, filed by Alnylam Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 6/2/2023. (kmd) (Entered: 06/02/2023) (0) |
| Jun 2, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney William G. Gaede, III, Sarah Chapin Columbia, Ian B. Brooks, Sarah J. Fischer, Bhanu K. Sadasivan, Timothy M. Dunker, Anisa Noorassa - filed by Alnylam Pharmaceuticals, Inc.. (Townsend, Ethan) (Entered: 06/02/2023) (9) |
| Jun 1, 2023 | 8 | STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:23-cv-00578-CFC, 1:23-cv-00580-CFC(nmf) (Entered: 06/01/2023) (2) |
| Jun 1, 2023 | 7 | SUMMONS Returned Executed by Alnylam Pharmaceuticals, Inc..Pharmacia & Upjohn Co. LLC served on 5/26/2023, answer due 6/16/2023. (Townsend, Ethan) (Entered: 06/01/2023) (2) |
| Jun 1, 2023 | 6 | SUMMONS Returned Executed by Alnylam Pharmaceuticals, Inc..Pfizer Inc. served on 5/26/2023, answer due 6/16/2023. (Townsend, Ethan) (Entered: 06/01/2023) (2) |
| May 31, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:23-cv-00578-CFC, 1:23-cv-00580-CFC (rjb) (Entered: 05/31/2023) (0) |
| May 26, 2023 | 5 | Summons Issued as to Pfizer Inc. and Pharmacia & Upjohn Co. LLC on 5/26/2023. (Attachments: # 1 Summons Issued Pharmacia & Upjohn Co. LLC)(jfm) (Entered: 05/26/2023) (0) |
| May 26, 2023 | 4 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alnylam Pharmaceuticals, Inc. (jfm) (Entered: 05/26/2023) (1) |
| May 26, 2023 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,633,479 B2; US 11,633,480 B2; US 11,612,657 B2; US 11,590,229 B2. (jfm) (Entered: 05/26/2023) (1) |
| May 26, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 05/26/2023) (3) |
| May 26, 2023 | 1 | Complaint* (1) |
